Medico Remedies shareholders approve FY26 accounts, director reappointments
- Medico Remedies held its 32nd AGM on September 22, 2026, via video conferencing
- Shareholders approved audited financial statements for FY26 and director reappointments
- Only 34 members attended the virtual meeting to cast votes on seven resolutions
- Chairman Haresh Mehta addressed shareholder queries on new manufacturing unit operations
*this image is generated using AI for illustrative purposes only.
Medico Remedies held its 32nd Annual General Meeting (AGM) on September 22, 2026, via Video Conferencing. Shareholders adopted the audited financial statements for the fiscal year ended March 31, 2026, and approved key board reappointments.
The meeting was presided over by Haresh Mehta, Chairman and Whole-Time Director. Due to low attendance, only 34 members participated through the virtual platform. The notice convening the meeting and the Auditors' Report were taken as read, with statutory documents available for inspection.
Key resolutions passed
The AGM addressed both ordinary and special business items, focusing on leadership continuity and remuneration adjustments.
| Item | Description | Status |
|---|---|---|
| Financials | Adoption of audited FY26 financial statements | Approved |
| Rotation | Reappointment of Haresh Kapurlal Mehta (DIN: 01080289) | Approved |
| Special Business | Reappointment of Rishit Mehta as Whole-Time Director | Approved |
| Special Business | Reappointment of Haresh Mehta as Chairman & Whole-Time Director | Approved |
| Remuneration | Increase in pay for Harshit Mehta (Managing Director) | Approved |
| Professional Fees | Increase in fees for Priyal Rishit Mehta (Consultant) | Approved |
| Remuneration | Increase in pay for Shweta Harshit Mehta (Regulatory Deputy Manager) | Approved |
Operational overview and shareholder queries
During the session, the Chairman provided an overview of the company's operations and financial performance for FY26, along with its future outlook. Two registered shareholders raised questions regarding the status of operations at both existing and new manufacturing units. These queries were satisfactorily answered by the Chairman.
Voting and compliance details
Ms. Shreya Shah, a Practicing Company Secretary, served as the Scrutinizer to supervise the e-voting process. The combined report on voting results from remote e-voting and live e-voting will be submitted to stock exchanges and published on the company website within two working days of the meeting's conclusion. The meeting commenced at 4:00 pm and concluded at 4:15 pm, with e-voting remaining open for 15 minutes post-AGM.
Historical Stock Returns for Medico Remedies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.29% | -8.34% | -20.38% | -10.98% | -12.25% | +40.33% |
How will the approved remuneration increases for key management personnel impact Medico Remedies' operating margins in the upcoming fiscal year?
What specific capacity expansion or product line additions are planned for the new manufacturing units mentioned during shareholder queries?
Given the low attendance of only 34 members, what steps is the board taking to improve retail shareholder engagement and voting participation in future meetings?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
